Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limitedverified

CUV.AX

Price:

$11.54

Market Cap:

$577.70M

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a c...[Read more]

Industry

Biotechnology

IPO Date

2001-02-11

Stock Exchange

ASX

Ticker

CUV.AX

The Current Ratio as of January 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CUV.AX) is 8.81

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 8.81. This represents a change of 10.44% compared to the average of 7.98 of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CUV.AX) Historical Current Ratio (quarterly & annually)

How has CUV.AX Current Ratio performed in the past?

The mean historical Current Ratio of Clinuvel Pharmaceuticals Limited over the last ten years is 9.52. The current 8.81 Current Ratio has changed 9.15% with respect to the historical average. Over the past ten years (40 quarters), CUV.AX's Current Ratio was at its highest in in the December 2018 quarter at 17.54. The Current Ratio was at its lowest in in the March 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

9.52

Median

9.07

Minimum

5.57

Maximum

12.33

Clinuvel Pharmaceuticals Limited (CUV.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 56.59%

Maximum Annual Current Ratio = 12.33

Minimum Annual Increase = -43.79%

Minimum Annual Current Ratio = 5.57

Quarterly (TTM)
Annual
YearCurrent RatioChange
20248.8118.42%
20237.44-27.35%
202210.24-13.33%
202111.8129.85%
20209.10-26.22%
201912.331.24%
201812.1834.64%
20179.043.63%
20168.7356.59%
20155.57-43.79%

Clinuvel Pharmaceuticals Limited (CUV.AX) Average Current Ratio

How has CUV.AX Current Ratio performed in the past?

The current Current Ratio of Clinuvel Pharmaceuticals Limited (CUV.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.83

5-year avg

9.48

10-year avg

9.52

Clinuvel Pharmaceuticals Limited (CUV.AX) Current Ratio vs. Peers

How is CUV.AX’s Current Ratio compared to its peers?

Clinuvel Pharmaceuticals Limited’s Current Ratio is greater than Pro Medicus Limited (5.98), greater than Nanosonics Limited (6.16), greater than PolyNovo Limited (3.41), greater than Fisher & Paykel Healthcare Corporation Limited (1.83), greater than AVITA Medical, Inc. (8.18),

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CUV.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CUV.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Clinuvel Pharmaceuticals Limited's Current Ratio?

How is the Current Ratio calculated for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the highest Current Ratio for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the 3-year average Current Ratio for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the 5-year average Current Ratio for Clinuvel Pharmaceuticals Limited (CUV.AX)?

How does the current Current Ratio for Clinuvel Pharmaceuticals Limited (CUV.AX) compare to its historical average?